KELLY LOWE: Open Payments
NPI 1457887622 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 20 payments from 7 companies in 2025. Trend: 2023 $503 · 2024 $439 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $105 |
| Abbott Laboratories | 4 | $83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $54 |
| Novo Nordisk Inc | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: REPATHA, CARDIOMEMS, LifeVest, Wegovy, SAPIEN 3 Ultra RESILIA, LEQVIO.
Industry payments across IN — which companies pay providers there.
